HomeVYGR • NASDAQ
add
Voyager Therapeutics Inc
Previous close
$4.87
Day range
$4.35 - $4.91
Year range
$2.65 - $5.55
Market cap
265.52M USD
Avg Volume
773.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 15.34M | 144.28% |
Operating expense | 8.22M | -8.65% |
Net income | -27.43M | 20.47% |
Net profit margin | -178.83 | 67.45% |
Earnings per share | -0.47 | 20.34% |
EBITDA | -25.38M | 31.93% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 196.45M | -26.34% |
Total assets | 252.28M | -35.81% |
Total liabilities | 56.20M | -39.76% |
Total equity | 196.08M | — |
Shares outstanding | 59.60M | — |
Price to book | 1.47 | — |
Return on assets | -24.45% | — |
Return on capital | -26.93% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -27.43M | 20.47% |
Cash from operations | -30.26M | -108.29% |
Cash from investing | 47.42M | 274.33% |
Cash from financing | 136.00K | -76.31% |
Net change in cash | 17.30M | 142.03% |
Free cash flow | -17.11M | -533.73% |
About
Founded
2013
Headquarters
Website
Employees
141
